Morgan Stanley downgraded HP Inc. (NYSE:) from Obese to Equal-Weight in a word to purchasers Monday, citing restricted upside in each valuation and future earnings estimates.
Regardless of HP’s latest inventory efficiency, the agency believes that the constructive catalysts driving the corporate’s progress have now been totally priced in.
Morgan Stanley’s analysts famous that HPQ is presently buying and selling at roughly 10 occasions its price-to-earnings (P/E) ratio, which is round one customary deviation above its historic common.
With the corporate’s “shares now buying and selling at ~10x P/E, simply 10% off all-time highs, we consider these components have now been largely priced in,” Morgan Stanley acknowledged.
The agency initially upgraded HPQ to Obese in December 2023, pushed by the assumption that the market was underestimating a restoration in Private Programs income progress, steady print margins, and accelerating capital returns.
Nevertheless, after a 14-point outperformance over the past six months, analysts see restricted room for additional progress.
“We see restricted room for a number of growth from right here,” they added, notably as their forecasts already suggest peak progress charges for FY25.
Morgan Stanley additionally expressed considerations about weaker-than-expected PC demand within the second half of the yr and potential declines in print margins as a result of a destructive combine shift.
With HPQ’s F4Q earnings report approaching on August twenty eighth, the agency’s income and EPS forecasts are 3% beneath consensus, leading to them “taking some chips off the desk” and downgrading the inventory. The worth goal stays unchanged at $37.
